Wary pharma: AstraZeneca sours on UK

Is artificial intelligence becoming uncontrollably powerful? Our correspondent analyses whether a pause to breakneck development is possible or feasible. We have entered the new age of the orator. And why cheese is getting more popular in India. Guests and host:Alex Hern, AI writ ...  Show more

Though a growing share of the British population is anxious about Islam, they have no reason to be. Islamism, a fringe ideology that believes government and society should be guided by Islamic principles, is the real concern. America cracks down on multinationals’ efforts to shif ...  Show more

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean a ...  Show more

AstraZeneca has drawn up plans to break out its China business, and France is challenging a German-led plan to build up Europe’s air defences. Plus, US businesses are cutting back on their investments in diversity and inclusion. 

Mentioned in this p ...

An AstraZeneca vaccine trial on children gets put on pause while a possible link with rare blood clots is investigated. And former Bank of England governor, Mark Carney, talks climate change, fintech and... should Adam sell his Bitcoin? Today’s Newscast was made by Sam Bonham wit ...  Show more

The UK blocks some arms shipments to Israel, audit firms are fighting against new oversight rules in the US, and the same technology that brought us Covid-19 vaccines could also be used to fight cancer. Plus, the Oasis revival tour is so popular it triggered a UK investigation ...